Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Beijing Succeeder Technology OCF Margin %?
Beijing Succeeder TechnologySHSE:688338 -5.05%86 OCF Margin % is 34.24% as of Mar. 2026, which is 9% above its 10-year median of 31.33. GuruFocus rates SHSE:688338 with a GF Score™ of 86/100 and a GF Value™ of ¥30.49 (Fairly Valued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Beijing Succeeder Technology ranks better than 97.18% on this metric.
The historical rank and industry rank for Beijing Succeeder Technology's OCF Margin % or its related term are showing as below:
SHSE:688338'
s OCF Margin % Range Over the Past 10 Years
Min: 20.85 Med: 31.33 Max: 44.78
Current: 37.28
During the past 10 years, the highest OCF Margin % of Beijing Succeeder Technology was 44.78%. The lowest was 20.85%. And the median was 31.33%.
SHSE:688338's OCF Margin % is ranked better than 97.18% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs SHSE:688338: 37.28
Beijing Succeeder Technology OCF Margin % Related Terms
Beijing Succeeder Technology OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688338 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Beijing Succeeder Technology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Succeeder Technology OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Beijing Succeeder Technology's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Succeeder Technology (SHSE:688338) has a OCF Margin % of 34.24% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Beijing Succeeder Technology and its competitors. This is near median its historical median of 31.33. Over the past decade, Beijing Succeeder Technology's OCF Margin % has ranged from 20.85 to 44.78. According to the industry distribution chart, Beijing Succeeder Technology ranks #23 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 2.8%.
Is Beijing Succeeder Technology's OCF Margin % too high?
Beijing Succeeder Technology's current OCF Margin % of 34.24% is near median its 10-year median of 31.33. Over the past 10 years, this metric has ranged from a low of 20.85 to a high of 44.78. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Beijing Succeeder Technology's value of 34.24% is 488.3% above this industry median. Based on the distribution chart, Beijing Succeeder Technology ranks #23 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Succeeder Technology has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Succeeder Technology's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Succeeder Technology ranks #23 out of 815 companies for OCF Margin %. This places Beijing Succeeder Technology in the top 3% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.82. Beijing Succeeder Technology's value of 34.24% is 488.3% above this benchmark. Historically, Beijing Succeeder Technology's own OCF Margin % has ranged from 20.85 to 44.78 over the past decade. While the company's 10-year median is 31.33 vs. the industry median of 5.82, Beijing Succeeder Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Succeeder Technology's current OCF Margin % of 34.24% is 488.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Beijing Succeeder Technology and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Succeeder Technology's current OCF Margin % is 34.24%, which is near median its own 10-year median of 31.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Succeeder Technology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Succeeder Technology (SHSE:688338) is currently considered Fairly Valued. The stock's GF Value™ is ¥30.49, compared to a current price of ¥29.13 — trading 4.5% below its estimated fair value. The current OCF Margin % is 34.24%, which is near median its 10-year median of 31.33 and 488.3% above the Medical Devices & Instruments industry median of 5.82. Beijing Succeeder Technology's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Beijing Succeeder Technology (SHSE:688338), the current OCF Margin % is 34.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Succeeder Technology (SHSE:688338) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Succeeder Technology stock appears to be undervalued.
The current stock price of ¥29.13 is trading 4.5% below its estimated GF Value™ of ¥30.49.
GuruFocus considers Beijing Succeeder Technology to be Fairly Valued.
Key valuation signals for SHSE:688338:
OCF Margin %: 34.24% (near median its 10-year median of 31.33)
GF Value™: ¥30.49 vs. price of ¥29.13 (4.5% below fair value)
Industry Position: 488.3% above the Medical Devices & Instruments median (#23 of 815)
No single metric tells the full story. See the SHSE:688338 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
86GF Score
Get the complete analysis for SHSE:688338
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688338 has been successfully added to your 
